Grace Capital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $484K | Buy |
3,738
+207
| +6% | +$26.8K | 0.29% | 96 |
|
|
2021
Q3 | $400K | Buy |
3,531
+155
| +5% | +$17.6K | 0.25% | 111 |
|
|
2021
Q2 | $350K | Buy |
3,376
+260
| +8% | +$27K | 0.23% | 107 |
|
|
2021
Q1 | $261K | Buy |
3,116
+58
| +2% | +$4.86K | 0.17% | 135 |
|
|
2020
Q4 | $279K | Sell |
3,058
-410
| -12% | -$37.4K | 0.18% | 127 |
|
|
2020
Q3 | $277K | Buy |
3,468
+258
| +8% | +$20.6K | 0.21% | 105 |
|
|
2020
Q2 | $222K | Buy |
+3,210
| New | +$222K | 0.19% | 113 |
|
|
2020
Q1 | – | Sell |
-3,189
| Closed | -$248K | – | 187 |
|
|
2019
Q4 | $248K | Buy |
+3,189
| New | +$248K | 0.2% | 115 |
|
|
2019
Q3 | – | Sell |
-26,070
| Closed | -$1.61M | – | 150 |
|
|
2019
Q2 | $1.61M | Sell |
26,070
-13,494
| -34% | -$831K | 0.77% | 41 |
|
|
2019
Q1 | $2.52M | Sell |
39,564
-2,046
| -5% | -$130K | 0.98% | 26 |
|
|
2018
Q4 | $2.12M | Sell |
41,610
-5,124
| -11% | -$262K | 0.99% | 27 |
|
|
2018
Q3 | $2.71M | Sell |
46,734
-4,440
| -9% | -$258K | 1.06% | 29 |
|
|
2018
Q2 | $2.48M | Buy |
+51,174
| New | +$2.48M | 0.95% | 33 |
|